Search

Phu Hoang Nguyen

Examiner (ID: 14741, Phone: (571)272-5931 , Office: P/1747 )

Most Active Art Unit
1747
Art Unit(s)
1731, 1747, 1791
Total Applications
942
Issued Applications
511
Pending Applications
112
Abandoned Applications
343

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19164754 [patent_doc_number] => 11980636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Treatment of hematological disorders [patent_app_type] => utility [patent_app_number] => 17/530245 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 42 [patent_no_of_words] => 15098 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/530245
Treatment of hematological disorders Nov 17, 2021 Issued
Array ( [id] => 18861830 [patent_doc_number] => 20230416265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => COMPOUNDS FOR THE DETECTION OF HEME OXYGENASE 1 (HO-1), AND METHODS AND USES INVOLVING THE SAME [patent_app_type] => utility [patent_app_number] => 18/252597 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 333 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252597 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/252597
COMPOUNDS FOR THE DETECTION OF HEME OXYGENASE 1 (HO-1), AND METHODS AND USES INVOLVING THE SAME Nov 11, 2021 Pending
Array ( [id] => 18842517 [patent_doc_number] => 20230404921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE [patent_app_type] => utility [patent_app_number] => 18/250942 [patent_app_country] => US [patent_app_date] => 2021-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250942 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/250942
LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE Oct 28, 2021 Pending
Array ( [id] => 18830853 [patent_doc_number] => 20230399378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => PEPTIDE-BASED DELIVERY OF AGENTS [patent_app_type] => utility [patent_app_number] => 18/034526 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034526 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/034526
PEPTIDE-BASED DELIVERY OF AGENTS Oct 27, 2021 Pending
Array ( [id] => 17532389 [patent_doc_number] => 20220110998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => ESSENTIAL OIL EMULSION NOSTRIL TREATMENT COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/512306 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9217 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512306 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/512306
Essential oil emulsion nostril treatment composition Oct 26, 2021 Issued
Array ( [id] => 18818813 [patent_doc_number] => 20230393153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => DIAGNOSTIC AND THERAPY OF TRAUMATIC BRAIN INJURY [patent_app_type] => utility [patent_app_number] => 18/033029 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033029 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/033029
DIAGNOSTIC AND THERAPY OF TRAUMATIC BRAIN INJURY Oct 21, 2021 Pending
Array ( [id] => 18842751 [patent_doc_number] => 20230405155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG [patent_app_type] => utility [patent_app_number] => 18/034108 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23562 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034108 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/034108
NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG Oct 19, 2021 Pending
Array ( [id] => 17519183 [patent_doc_number] => 20220105031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => METHOD FOR ADMINISTERING LIPOSOMAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/505119 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/505119
Method for administering liposomal composition Oct 18, 2021 Issued
Array ( [id] => 18226916 [patent_doc_number] => 20230065910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => NANO-ARMORED SINGLE CELL PRODUCT FOR TREATING PARKINSON'S DISEASE THROUGH BACTERIA AND A PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/503561 [patent_app_country] => US [patent_app_date] => 2021-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503561 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/503561
Nano-armored single cell product for treating Parkinson's disease through bacteria and a preparation method thereof Oct 17, 2021 Issued
Array ( [id] => 17761765 [patent_doc_number] => 20220235377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => METHODS OF LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM [patent_app_type] => utility [patent_app_number] => 17/500491 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79445 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/500491
Methods of lipid nanoparticle manufacture and compositions derived therefrom Oct 12, 2021 Issued
Array ( [id] => 19622947 [patent_doc_number] => 12161739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Peroxymonosulfate toothpowder composition for tenacious stains [patent_app_type] => utility [patent_app_number] => 17/497503 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6357 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497503 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/497503
Peroxymonosulfate toothpowder composition for tenacious stains Oct 7, 2021 Issued
Array ( [id] => 18707690 [patent_doc_number] => 20230330272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 18/023360 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023360 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023360
COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME Oct 4, 2021 Pending
Array ( [id] => 17355239 [patent_doc_number] => 20220016035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => Extended Release Highly Loaded Drug Compositions [patent_app_type] => utility [patent_app_number] => 17/489137 [patent_app_country] => US [patent_app_date] => 2021-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489137 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/489137
Extended Release Highly Loaded Drug Compositions Sep 28, 2021 Pending
Array ( [id] => 19716208 [patent_doc_number] => 12201724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-21 [patent_title] => Lecithin vesicles for oral delivery [patent_app_type] => utility [patent_app_number] => 17/483129 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 11112 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/483129
Lecithin vesicles for oral delivery Sep 22, 2021 Issued
Array ( [id] => 19439998 [patent_doc_number] => 12090225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Specially formulated compositions of inhaled nintedanib and nintedanib salts [patent_app_type] => utility [patent_app_number] => 17/469594 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58702 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469594 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/469594
Specially formulated compositions of inhaled nintedanib and nintedanib salts Sep 7, 2021 Issued
Array ( [id] => 18691058 [patent_doc_number] => 20230321251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT [patent_app_type] => utility [patent_app_number] => 18/024459 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024459 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/024459
LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT Sep 2, 2021 Pending
Array ( [id] => 18581562 [patent_doc_number] => 20230263814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/024040 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -97 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024040 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/024040
METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS Aug 29, 2021 Abandoned
Array ( [id] => 19195334 [patent_doc_number] => 11992553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Inhalable powder formulations of alginate oligomers [patent_app_type] => utility [patent_app_number] => 17/445577 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 18424 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445577
Inhalable powder formulations of alginate oligomers Aug 19, 2021 Issued
Array ( [id] => 18656260 [patent_doc_number] => 20230302154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/041811 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041811 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/041811
NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF Aug 18, 2021 Pending
Array ( [id] => 18724353 [patent_doc_number] => 20230338495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => Vaccine Compositions and Antibodies For Lyme Disease [patent_app_type] => utility [patent_app_number] => 18/022087 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022087 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022087
Vaccine Compositions and Antibodies For Lyme Disease Aug 18, 2021 Pending
Menu